• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Cinchona alkaloids Cinchona alkaloids
• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Cinchona alkaloids

Comprehensive Guide to (-)-O-(9)-Allyl-N-(9-anthracenylmethyl) cinchonidinium bromide (CAS No. 200132-54-3)

(-)-O-(9)-Allyl-N-(9-anthracenylmethyl) cinchonidinium bromide (CAS No. 200132-54-3) is a specialized chiral quaternary ammonium salt derived from cinchonidine, a naturally occurring alkaloid. This compound has garnered significant attention in the fields of asymmetric synthesis, catalysis, and pharmaceutical research due to its unique structural properties. The integration of an allyl group and an anthracenylmethyl moiety enhances its utility as a phase-transfer catalyst (PTC) and a chiral selector in enantioselective reactions. Researchers and industries are increasingly exploring its applications in green chemistry and sustainable synthesis, aligning with global trends toward eco-friendly methodologies.

The molecular structure of (-)-O-(9)-Allyl-N-(9-anthracenylmethyl) cinchonidinium bromide features a cinchonidine backbone, which is known for its stereochemical rigidity and ability to induce chirality in reaction products. The allyl group at the O-(9) position and the anthracenylmethyl group at the N-position contribute to its solubility in organic solvents and its efficacy in phase-transfer catalysis. These attributes make it a valuable tool for asymmetric alkylation, epoxidation, and other enantioselective transformations. Recent studies highlight its role in reducing waste and improving atom economy, addressing key concerns in modern synthetic chemistry.

One of the most prominent applications of (-)-O-(9)-Allyl-N-(9-anthracenylmethyl) cinchonidinium bromide is in the synthesis of optically active pharmaceuticals. The compound’s ability to facilitate high enantiomeric excess (ee) in reactions is critical for producing drugs with fewer side effects and improved efficacy. For instance, it has been employed in the synthesis of beta-blockers, antiviral agents, and other bioactive molecules. The growing demand for enantiopure drugs in the pharmaceutical industry has spurred interest in this catalyst, making it a hot topic in medicinal chemistry forums and research publications.

In addition to pharmaceutical applications, (-)-O-(9)-Allyl-N-(9-anthracenylmethyl) cinchonidinium bromide is used in material science, particularly in the development of chiral materials for sensors and optoelectronic devices. Its anthracene moiety provides fluorescence properties, enabling its use in probing molecular interactions and designing light-responsive systems. Researchers are also investigating its potential in nanotechnology, where chiral catalysts play a pivotal role in the fabrication of nanostructured materials with tailored properties.

The market for chiral catalysts like (-)-O-(9)-Allyl-N-(9-anthracenylmethyl) cinchonidinium bromide is expanding rapidly, driven by advancements in asymmetric synthesis and the pharmaceutical industry’s shift toward single-enantiomer drugs. Suppliers and manufacturers are focusing on scalable synthesis methods to meet the rising demand. Analytical techniques such as HPLC, NMR, and mass spectrometry are routinely employed to ensure the purity and quality of this compound, which is often supplied as a high-purity powder or in solution form. Storage recommendations typically emphasize protection from light and moisture to maintain stability.

Frequently asked questions about (-)-O-(9)-Allyl-N-(9-anthracenylmethyl) cinchonidinium bromide include inquiries about its solubility profile, catalytic efficiency, and compatibility with various reaction conditions. Researchers often search for protocols detailing its use in specific transformations, such as asymmetric phase-transfer catalysis or enantioselective fluorination. The compound’s CAS No. 200132-54-3 is a key identifier for sourcing and regulatory compliance, ensuring accurate procurement and documentation in laboratory and industrial settings.

Environmental and safety considerations for (-)-O-(9)-Allyl-N-(9-anthracenylmethyl) cinchonidinium bromide are aligned with standard laboratory practices. While it is not classified as a hazardous material, proper handling, including the use of personal protective equipment (PPE) and adequate ventilation, is recommended. Disposal should follow institutional guidelines for organic compounds. The compound’s role in green chemistry initiatives further underscores its appeal, as it often reduces the need for toxic reagents and harsh reaction conditions.

In summary, (-)-O-(9)-Allyl-N-(9-anthracenylmethyl) cinchonidinium bromide (CAS No. 200132-54-3) is a versatile and high-value chiral catalyst with broad applications in pharmaceuticals, materials science, and nanotechnology. Its unique structural features, including the allyl and anthracenylmethyl groups, enhance its catalytic performance and selectivity. As the demand for enantiopure compounds grows, this catalyst is poised to play an increasingly important role in cutting-edge research and industrial processes. Researchers and suppliers alike are encouraged to stay updated on the latest developments to fully leverage its potential.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)